First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.

<h4>Objective</h4>The objective of the study was to evaluate risk assessment for gestational hypertension based on the profile of circulating placental specific C19MC microRNAs in early pregnancy.<h4>Study design</h4>The prospective longitudinal cohort study of women enrolled...

Full description

Bibliographic Details
Main Authors: Ilona Hromadnikova, Katerina Kotlabova, Lucie Hympanova, Jindrich Doucha, Ladislav Krofta
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0113735
id doaj-56712e4187d94cb5a3c31d313ec0364d
record_format Article
spelling doaj-56712e4187d94cb5a3c31d313ec0364d2021-03-04T08:40:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11373510.1371/journal.pone.0113735First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.Ilona HromadnikovaKaterina KotlabovaLucie HympanovaJindrich DouchaLadislav Krofta<h4>Objective</h4>The objective of the study was to evaluate risk assessment for gestational hypertension based on the profile of circulating placental specific C19MC microRNAs in early pregnancy.<h4>Study design</h4>The prospective longitudinal cohort study of women enrolled at first trimester screening at 10 to 13 weeks was carried out (n = 267). Relative quantification of placental specific C19MC microRNAs (miR-516-5p, miR-517*, miR-518b, miR-520a*, miR-520h, miR-525 and miR-526a) was determined in 28 normal pregnancies and 18 pregnancies which developed gestational hypertension using real-time PCR and a comparative Ct method relative to synthetic C. elegans microRNA (cel-miR-39).<h4>Results</h4>Increased extracellular C19MC microRNA plasmatic levels (miR-516-5p, p<0.001; miR-517*, p = 0.007; miR-520h, p<0.001; miR-518b, p = 0.002) were detected in patients destined to develop gestational hypertension. MiR-520h had the best predictive performance with a PPV of 84.6% at a 7.1% false positive rate. The combination of miR-520h and miR-518b was able to predict 82.6% of women at the same false positive rate. The overall predictive capacity of single miR-518b (73.3% at 14.3% FPR), miR-516-5p (70.6% at 17.9% FPR) and miR-517* (57.9% at 28.6% FPR) biomarkers was lower.<h4>Conclusion</h4>The study brought interesting finding that the up-regulation of miR-516-5p, miR-517*, miR-520h and miR-518b is associated with a risk of later development of gestational hypertension. First trimester screening of extracellular miR-520h alone or in combination with miR-518b identified a significant proportion of women with subsequent gestational hypertension.https://doi.org/10.1371/journal.pone.0113735
collection DOAJ
language English
format Article
sources DOAJ
author Ilona Hromadnikova
Katerina Kotlabova
Lucie Hympanova
Jindrich Doucha
Ladislav Krofta
spellingShingle Ilona Hromadnikova
Katerina Kotlabova
Lucie Hympanova
Jindrich Doucha
Ladislav Krofta
First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
PLoS ONE
author_facet Ilona Hromadnikova
Katerina Kotlabova
Lucie Hympanova
Jindrich Doucha
Ladislav Krofta
author_sort Ilona Hromadnikova
title First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
title_short First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
title_full First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
title_fullStr First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
title_full_unstemmed First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
title_sort first trimester screening of circulating c19mc micrornas can predict subsequent onset of gestational hypertension.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description <h4>Objective</h4>The objective of the study was to evaluate risk assessment for gestational hypertension based on the profile of circulating placental specific C19MC microRNAs in early pregnancy.<h4>Study design</h4>The prospective longitudinal cohort study of women enrolled at first trimester screening at 10 to 13 weeks was carried out (n = 267). Relative quantification of placental specific C19MC microRNAs (miR-516-5p, miR-517*, miR-518b, miR-520a*, miR-520h, miR-525 and miR-526a) was determined in 28 normal pregnancies and 18 pregnancies which developed gestational hypertension using real-time PCR and a comparative Ct method relative to synthetic C. elegans microRNA (cel-miR-39).<h4>Results</h4>Increased extracellular C19MC microRNA plasmatic levels (miR-516-5p, p<0.001; miR-517*, p = 0.007; miR-520h, p<0.001; miR-518b, p = 0.002) were detected in patients destined to develop gestational hypertension. MiR-520h had the best predictive performance with a PPV of 84.6% at a 7.1% false positive rate. The combination of miR-520h and miR-518b was able to predict 82.6% of women at the same false positive rate. The overall predictive capacity of single miR-518b (73.3% at 14.3% FPR), miR-516-5p (70.6% at 17.9% FPR) and miR-517* (57.9% at 28.6% FPR) biomarkers was lower.<h4>Conclusion</h4>The study brought interesting finding that the up-regulation of miR-516-5p, miR-517*, miR-520h and miR-518b is associated with a risk of later development of gestational hypertension. First trimester screening of extracellular miR-520h alone or in combination with miR-518b identified a significant proportion of women with subsequent gestational hypertension.
url https://doi.org/10.1371/journal.pone.0113735
work_keys_str_mv AT ilonahromadnikova firsttrimesterscreeningofcirculatingc19mcmicrornascanpredictsubsequentonsetofgestationalhypertension
AT katerinakotlabova firsttrimesterscreeningofcirculatingc19mcmicrornascanpredictsubsequentonsetofgestationalhypertension
AT luciehympanova firsttrimesterscreeningofcirculatingc19mcmicrornascanpredictsubsequentonsetofgestationalhypertension
AT jindrichdoucha firsttrimesterscreeningofcirculatingc19mcmicrornascanpredictsubsequentonsetofgestationalhypertension
AT ladislavkrofta firsttrimesterscreeningofcirculatingc19mcmicrornascanpredictsubsequentonsetofgestationalhypertension
_version_ 1714807661322567680